,24 Although ABCA1 has not been previously implicated in ALS, consistent evidence of dysregulated cholesterol metabolism—particularly reduced HDL and apoA-I levels—in ALS and related neurodegenerative disorders supports the biological plausibility of its protective role identified in this study.25 This evidence concerns the gene APOA1 and amyotrophic lateral sclerosis.